PACK Ranpak Holdings Corp.
Ranpak Holdings Corp., together with its subsidiaries, provides product protection solutions and end-of-line automation solutions for e-commerce and industrial supply chains in North America, Europe, and Asia. The company offers protective packaging solutions, such as void-fill protective systems that convert paper to fill empty spaces in secondary packages and protect objects under the FillPak brand; cushioning protective systems, which convert paper into cushioning pads under the PadPak brand; wrapping protective systems that create pads or paper mesh to wrap and protect fragile items, as well as to line boxes and provide separation when shipping various objects under the WrapPak and Geami brands; and cold chain products, which are used to provide insulation for temperature controlled goods during transport. It also provides end-of-line packaging automation for product distribution and shipping, as well as products that help end users automate the void filling and box closure processes after product packing is complete. The company sells its products to end users primarily through a distributor network and directly to end-users. The company was founded in 1972 and is headquartered in Concord Township, Ohio.…
Industry Peers
Packaging & ContainersKey Statistics
About Ranpak Holdings (NYSE: PACK)
›
Ranpak Holdings (NYSE: PACK) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Packaging & Containers industry, part of the Consumer Cyclical sector, and reports about 800 employees.
The shares were at 2.940 USD on 19 November 2026, down 39.4% over 52 weeks. Its 52-week range is 2.870 USD to 7.810 USD: the price is 62.4% below the high and 2.4% above the low.
Its market capitalisation is 252.21M USD.
Ranpak Holdings reports return on equity of -7.2%, an operating margin of 1.3% and revenue up 2.3% year over year.
Its debt exceeds its cash by 381.50M USD, a debt-to-equity ratio of 0.80. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 5.167 USD is 75.7% above the current price. The next earnings report is expected on 4 March 2027.